1. Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial. (April 2023) Authors: TAO, Yungan; Sun, Xu-Shan; Pointreau, Yoann; Le Tourneau, Christophe; Sire, Christian; Kaminsky, Marie-Christine; Coutte, Alexandre; Alfonsi, Marc; Calderon, Benôit; Boisselier, Pierre; Martin, Laurent; Miroir, Jessica; Ramee, Jean-Francois; Delord, Jean-Pierre; Clatot, Florian; Rolland, Frederic... Journal: European journal of cancer Issue: Volume 183(2023) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer. Issue 6 (1st July 2012) Authors: Dizon, Don S.; Damstrup, Lars; Finkler, Neil J.; Lassen, Ulrik; Celano, Paul; Glasspool, Ros; Crowley, Elizabeth; Lichenstein, Henri S.; Knoblach, Poul; Penson, Richard T. Journal: International journal of gynecological cancer Issue: Volume 22:Issue 6(2012) Page Start: 979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗